Palvella Therapeutics, Inc. (PVLA)
88.02
-10.56
(-10.71%)
USD |
NASDAQ |
Dec 15, 16:00
88.02
0.00 (0.00%)
After-Hours: 16:05
Palvella Therapeutics EPS Diluted (Quarterly): -1.025 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Agenus, Inc. | 1.944 |
| Ligand Pharmaceuticals, Inc. | 5.685 |
| Pelthos Therapeutics, Inc. | -5.304 |
| Inhibrx Biosciences, Inc. | -2.278 |
| CEL-SCI Corp. | -1.365 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -11.34M |
| Total Expenses (Quarterly) | 11.34M |
| Enterprise Value | 1.119B |
| Earnings Yield | -7.46% |
| Normalized Earnings Yield | -7.130 |